Follow The Filings

PETS PetMed Express

PetMed Express earnings company data as of 7:30 PM ET 8/20

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q1 13 Aug EPS 0.12 — —
Rev — $51.2M —

Insider trades

Open-market buys and sales by PETS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PETS insider trades
  • $44K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Nina Capital Holdings Inc. 10% owner, +2 joint filers
    Buy
    $44K 25,000 shares at $1.75 +1% to stake
    Traded Jun 8 Filed Jun 9

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants and 1 sale back to the company.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,9.01
8-K 5.02,7.01,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02,5.07,9.01
8-K 1.01,7.01,9.01
SCHEDULE 13D/A —
8-K 5.02,9.01
DEF 14A
DEFA14A
8-K 2.02,9.01
10-K
8-K 5.08
SCHEDULE 13D —
10-Q
8-K 5.07
8-K/A 4.01,9.01
10-Q
10-Q
SCHEDULE 13D/A —
DEF 14A
8-K 4.01,9.01
8-K 1.01,3.03,5.02,8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.